References
- Griffin M R, Way W A, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988; 109: 359–63
- Amstrong C P, Blower J L. Nonsteroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987; 28: 527–32
- Graham D Y, Smith J L. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol 1988; 83: 1081–4
- Fries J F, Miller S R, Spitz P W, Williams C A, Hubert H B, Block D A. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use. Gastroenterology 1989; 96: 647–55
- Graham D Y, Agrawal N M, Roth S H. Prevention of NSAID-induced gastric ulcer with misoprostol multicentre, double-blind, placebo-controlled trial. Lancet 1988; 2: 1277–80
- Ensanullah R SB, Page M C, Tildesley G, Wood J R. Prevention of gastroduodenal damage induced by non-steroidal antiinflammatory drugs: controlled trial of ranitidine. Br Med J 1989; 149: 775–9
- Bertellini G, Butti A, Piantanida B, et al. Studies on glycoproteins of animal origin and on their derivatives. I and II. Arzneimittelforsch 1971; 21: 244–7
- Prino G, Lietti A, Allegra G. Antipeptic activity of a sulfated glycopeptide. Different behavior with purified human pepsin or human gastric juice. Am J Dig Dis 1972; 17: 863–7
- Guslandi M, Nannini D, Tittobello A. Effect of sulglycotide on gastric bicarbonate secretion in humans. Drugs Exp Clin Res 1985; 11: 682–5
- Biasco G, Paganelli G M, Di Febo G, Siringo S, Barbara L. Cell-kinetic alterations induced by aspirin in human gastric mucosa and their prevention by a cytoprotective agent. Digestion 1992; 51: 146–51
- Bianchi Porro G, Dobrilla G, Verme G, Gallo M, Petrillo M, Valentini M. Comparison of sulglycotide with cimetidine in short-term treatment of duodenal ulcer: double-blind controlled trial. Br Med J 1979; 2: 17
- Prino G, Paglialunga S, Nardi G, Lietti A. Inhibition of experimentally induced gastric ulcers in the rat by a new sulfated glycopeptide. Eur J Pharmacol 1971; 15: 119–26
- Lanza F L, Royer G L, Nelson R S. Endoscopic evaluation of the effects of aspirin, buffered aspirin and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980; 303: 136–8
- Caruso I, Bianchi Porro G. Gastroscopic evaluation of antiinflammatory agents. Br Med J 1980; 280: 75–80
- Todd P A, Sorkin E M. Diclofenac sodium: a reappraisal of its pharmacokinetic properties and therapeutic efficacy. Drugs 1988; 35: 244–85
- Larkai E N, Smith J L, Lidsky M D, Graham D Y. Gastrointestinal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 82: 1153–8
- Miller T A. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Gastroenterol 1983; 245: G601–23
- Robert A. Prostaglandins and gastrointestinal tract. Physiology of the gastrointestinal tract, L R Johnson. Raven Press, New York 1981; 1407–34
- Niada R, Mantovani M, Prino G, Omini C, Berti F. Sulglycotide displays cytoprotective activity in rat gastric mucosa. Int J Tiss Reac 1983; 3: 285–8
- Niada R, Malandrino S, Nardi G F, et al. Cytoprotection by sulglycotide: prevention of gastric necrosis in rat. Pharmacol Res Commun 1981; 13: 696–8
- Loizzi P, Semmola M V, D'Ingianna E, Trotta F. Effectiveness of sulglycotide (Gliptide) in prevention of gastric lesions from non-steroidal anti-inflammatory drugs in patients with rheumatic disease–a controlled double-blind endoscopic study vs placebo. Clin Trials 1990; 27: 164–74
- Agraval N M, Dajani E Z. Treatment and prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. Clin Pharmacol Res 1989; 9: 347–57
- Bardhan K D, Griffin W M, Fenn G C, Shield M J, Bjarnason I T. Prevention and reversal of NSAID damage by misoprostol. Gastroenterology 1991; 100: A30